October 14, 2009 |
Men who need prostate-cancer surgery are increasingly choosing minimally invasive techniques because such surgeries typically lead to shorter hospital stays and a reduced risk of some types of complications. But a new study suggests that the risk of the most serious complications may be higher with the new technology. Minimally invasive forms of radical prostatectomy (in which the prostate gland is removed), often including the use of a robot, are heavily advertised. Procedures relying on robotic surgery have increased from 1% to 40% of all radical prostatectomies from 2001 to 2006 and may be as high as 75% of all prostate cancer surgeries today.
July 6, 2001 |
When 43-year-old porn actor Tyce Bune goes to work these days, he makes sure to pack something extra in his briefcase along with the usual script and change of clothes: a vial of Viagra tablets. On a typical day, when filming can stretch on for 14 hours, Bune will strip down and have sex in front of a camera crew as many as three times. During busy times, he might work five days a week.
July 6, 2008 |
Lonely hearts may have one more thing to worry about -- erectile dysfunction. Crunching data from a five-year study of 959 men ages 55 to 75, Finnish researchers found that men with no signs of erectile dysfunction, who had sex once a week or more, were less likely to later develop erectile dysfunction than men who had sex less often. In fact, men who reported having intercourse fewer than once a week at the beginning of the study had twice the incidence of ED than those who had sex more often.
March 15, 2011 |
Cialis, Viagra, Levitra and other erectile dysfunction drugs are not considered necessary by the U.S. Department of Health & Human Services. Apparently many men disagree. Hence the $3.1 million charged to Medicare Part D for the drugs in 2007 and 2008. A new report from the department's Office of Inspector General chides the Centers for Medicare & Medicaid Services, which runs the labyrinthian Medicare program, for the error. Sure, the drug can be covered when prescribed for non-sexual reasons.
June 5, 2000
People in need of authoritative medical information on sexual health now have two new Web sites to contact. The American Foundation for Urologic Disease, a nonprofit organization, launched a Web site (http://www.impotence.org) last month. The site was created and is maintained by medical experts. It includes a chat area monitored by a physician, information about various treatments and a confidential registry for patients to receive regular updates on medical options.
February 11, 2005 |
Pfizer Inc. and Microsoft Corp. are teaming up to fight the slew of spam e-mails hawking Viagra that invade consumers' computers. The companies said they had filed a total of 17 lawsuits against defendants involved in the sale and distribution of the erectile dysfunction drug. The Redmond, Wash., software giant has targeted spammers before, but this is the first time the company has joined forces with a non-technology firm.
December 29, 2006 |
Pfizer Inc. won a trademark case blocking drug makers in China from copying its Viagra erectile dysfunction pills' blue diamond shape. A Beijing court ordered the three companies to pay a $38,000 fine to Pfizer, stop producing the blue, diamond-shaped pills -- which didn't contain the active ingredient in Viagra -- and print an apology in a Chinese legal newspaper, Pfizer said.
September 30, 2008 |
Watson Pharmaceuticals Inc.'s experimental drug for prostate enlargement reduced symptoms without significant blood pressure or heart side effects, the company said. Silodosin, which Corona-based Watson intends to sell as Rapaflo, had "minimal effects" on blood pressure and heart rate during yearlong tests in people who took it alone or in combination with drugs to treat erectile dysfunction, the company said.
July 18, 2012 |
Most patients diagnosed with early-stage prostate cancer will live just as long if they simply watch their cancers rather than have them surgically removed, according to the results of a landmark clinical trial that could upend the medical approach to a disease that affects 1 in 6 men. The study, which focused on cancers still confined to the prostate, should reassure patients who want to avoid distressing side effects of surgery - such as urinary incontinence...